Welcome to CDC Stacks | Reducing the burden of HPV-associated cancer and disease through vaccination in the US - 13182 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Reducing the burden of HPV-associated cancer and disease through vaccination in the US
  • Published Date:
    February 19, 2013
Filetype[PDF - 6.89 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Reducing the burden of HPV-associated cancer and disease through vaccination in the US
Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Communication. ; Centers for Disease Control and Prevention (U.S.), Office of Surveillance, Epidemiology and Laboratory Services., Public Health Informatics & Technology Program Office. ; National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Cancer Prevention and Control. ; ... More ▼
  • Series:
    Public health grand rounds ; 2013 February 19
  • Document Type:
  • Description:
    Reducing the burden of HPV-associated cancer and disease through vaccination in the US [streaming video] -- Public health importance of human papillomavirus infection and disease [PDF version of the PowerPoint presentation by Mona Saraiya, p. 1-17] -- Overview of HPV vaccines and impact monitoring [PDF version of the PowerPoint presentation by Eileen F. Dunne, p. 18-32] -- US HPV vaccination program : progress and challenges [PDF version of the PowerPoint presentation by Shannon Stokley, p. 33-50] -- What is needed to increase HPV vaccine coverage? [PDF version of the PowerPoint presentation by Amy B. Middleman, p. 51-69] -- Prevention of HPV-associated disease : global and domestic overview [PDF version of the PowerPoint presentation by Lauri Markowitz, p. 70-74].

    This session of Grand Rounds explored the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. HPV is the most common sexually transmitted infection in the United States. There are more than 40 HPV types, some of which cause cancers and others which cause genital warts. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease. Currently available HPV vaccines prevent infection from the HPV types that cause about 70% of cervical cancers and the majority of other HPV-attributable cancers. HPV vaccine has been recommended for routine vaccination of 11-12 year-old girls since 2006 and for 11-12 year-old boys since 2011. This session also provided more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.

  • Supporting Files:
    No Additional Files